Spinal Stenosis
Conditions
Keywords
Spinal Stenosis, Neurogenic claudication, Walking capacity, Exercises, Education, gait pattern characteristics
Brief summary
The aim of this study is to determine the effectiveness of a 6-week specific rehabilitation program combining education and exercises on walking capacity in patients with LSS causing NC. The intervention group will receive standardized education and specific exercises while the control group will only receive standardized education. The program in both groups will last for 6 weeks with 4 evaluation timepoints (baseline, week 2, week 4 and post-intervention assessment). The primary outcomes will be walking capacity measured with the Self-Paced Walking Test and the secondary outcomes will be back and leg pain intensity, LSS-related disability, self-efficacy, level of physical activity, anxiety and depression, physical activity level, gait pattern characteristics, balance, and global perceived change.
Interventions
Exercises: 3 training sessions per week that will last for 30 minutes. Sessions will start with 5 minutes of activation (walking on a treadmill or cycling). Then, participants will be asked to complete 5 exercises targeting lower limb strengthening (time: 18 minutes) followed by 2 exercises designed to improve balance and 3 stretching exercises for the lower limb (time: 7 minutes). Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.
Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.
Sponsors
Study design
Eligibility
Inclusion criteria
* being at least 50 years old * having a degenerative central LSS alone or in combination with other LSS types (e.g. foraminal, lateral) and/or a spondylolisthesis affecting one or multiple vertebral levels, confirmed by clinical history, physical examination and proper imaging * having NC associated with LSS * being able to speak and understand French * being willing to attend 3 intervention sessions per week * with a duration of signs and symptoms of at least 3 months * (7) being able to walk at least 20 meters without walking aid, but not being able to walk continuously for 30 minutes * being able to provide informed written consent.
Exclusion criteria
* congenital LSS, * symptomatic osteoarthritis (hip or knee) causing limited walking capacity * neurological disease affecting walking capacity such as Parkinson * uncontrolled diabetes * heart failure * intermittent claudication of vascular origin * impaired cognitive capacity * back or lower extremities surgery in the past 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in walking capacity | Baseline, week 2, week 4, week 6, week 12 | Walking capacity measure with the Self-Paced Walking Test (time) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in leg and back pain intensity | Baseline, week 2, week 4, week 6, week 12 | Leg and back pain intensity will be independently assessed using a 11-point numerical rating scale (from 0 to 10 points). Higher score indicates higher pain. |
| Change from baseline in lumbar spinal stenosis related disabiltity | Baseline, week 6, week 12 | Lumbar spinal stenosis related disability is measured with the French-Canadian version of the Swiss Spinal Stenosis Questionnaire. Pain, function and satisfaction related to lumbar spinal stenosis. Pain subscale score range from 7 to 35 with higher values indicate a worst outcome, Function subscale score range from 5 to 20 with higher values indicate a worst outcome, Satisfaction subscale score range from 6 to 24 with higher values indicate a worst outcome. The total score is composed of the three subscales and range from 18 to 79. |
| Changes from baseline in self-efficacy | Baseline, week 6, week 12 | Measured with Self-efficacy measured with the French-Canadian Chronic Pain Self-Efficacy Scale. Each question is rated on a numerical scale (from 1 to 10). Total is calculated using the mean of the 33-items scores and ranges from 1 to 10 with a higher score indicate higher self-efficacy. |
| Change from baseline in anxiety and depression | Baseline, week 6, week 12 | Measured with the French-Canadian adaptation of the Hospital Anxiety and Depression Scale. Total score range from 0 to 21 with higher score indicating symptoms of anxiety and/or depression. |
| Change from baseline in physical activity level | Baseline, week 6, week 12 | Physical activity level assessed with the \[Physical Activity Questionnaire for the Elderly\]. The questionnaire allows to place participants into one of the 3 categories (low, moderate or high physical activity level). Physical activity level is measured in time per day. |
| Patient's global impression of change | changes of the global impression of change throughout the study (baseline, week 2, week 4, week 6, week 12) | Global impression of change will be measured using a 7-point scale that ranges from 'very much improved' to 'very much worse' with 'no change' as the mid-point. |
| Change from baseline in biomechanical parameters of gait | Baseline, week 2, week 4, week 6, week 12 | Spatio-temporal parameters of gait measured with wearable inertial sensors (velocity (m/s)) |
| Change from baseline in lower extremity physical function and balance | Baseline, week 6, week 12 | Lower extremity physical function and balance measured with the Short Physical Performance Battery. Total score ranges from 0 to 12 with higher score indicating a better lower extremity physical function and balance. |
Countries
Canada